Novo Nordisk shares tumble after drug trial falls short Markets Shares in Danish drug giant Novo Nordisk have shed more than a sixth of their value after poor drug trial results sparked an investor selloff. The firm behind weight-loss drugs Ozempic and Wegovy saw its shares tumble by 16.7 per cent to 257.23 Danish Krone on Monday morning after trials of its new obesity shot, [...]
Weight-loss drugs ‘fundamentally changing’ the way Brits eat Retail The rise of weight-loss drugs is starting to affect supermarket sales, with experts warning that the sector is unprepared for the change this Christmas. More than one in ten Brits is set to host someone on GLP-1 medication this year, prompting less alcohol and fewer sweets on the menu. “There is a worry that Christmas [...]
Mounjaro sales help almost double Ely Lilly’s UK turnover The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during its latest financial year, it has been revealed. The division of the US group has posted a turnover of £889m for 2024, according to new accounts filed with Companies House. The new total [...]
Mounjaro and Wegovy demand helps Chemist4U sales double June 23, 2025 Increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind online pharmacy Chemist4U almost double. The Skelmersdale-based business has reported a turnover of £59.5m for the year to 30 September, 2024, according to new accounts filed with Companies House. The latest total comes after the firm behind Chemist4U [...]
Vitality to offer discounted weight loss drugs in UK first February 12, 2025 Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, which is UK’s third-largest health insurer behind Bupa and Axa, is to offer discounts of up to 20 per cent for medications such as Wegovy and Mounjaro to its 1.9 million members. The offer is to [...]
Ozempic and Wegovy: What happens when a drug goes viral? May 18, 2024 Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?